Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $473.7400 (-0.96%) ($473.1200 - $482.9800) on Tue. Mar. 24, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.84% (three month average) | RSI | 78 | Latest Price | $473.7400(-0.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.3% a day on average for past five trading days. | Weekly Trend | REGN advances 6.7% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(47%) XLV(38%) XBI(37%) QQQ(31%) SPY(29%) | Factors Impacting REGN price | REGN will decline at least -0.92% in a week (0% probabilities). VIXM(-12%) TLT(-6%) UUP(-2%) SHY(-2%) IGOV(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.92% (StdDev 1.84%) | Hourly BBV | 0 () | Intraday Trend | -1% | | | |
|
5 Day Moving Average | $479.81(-1.27%) | 10 Day Moving Average | $461.11(2.74%) | 20 Day Moving Average | $441.43(7.32%) | To recent high | -3.1% | To recent low | 19.4% | Market Cap | $50.23b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |